Table 1.

Patient demographic for each group

	Non-Viremic (n=22)	Prolonged Viremia (n=14)	CMV Disease (n=14)	p-value
Patient Age: median (range)	46 (21–59)	45 (22–62)	44 (26–64)	0.97a
Donor Age: median (range)	44 (20–58)	43 (27–64)	39 (19–58)	0.16a
Donor status
Sibling	16 (73%)	7 (50%)	7 (50%)	0.27b
URD	6 (27%)	7 (50%)	7 (50%)
Hematopoietic Progenitor Cell Source
Bone Marrow	5 (23%)	2 (14%)	0	0.16b
Peripheral Blood	17 (77%)	12 (86%)	14 (100%)
Diagnosis:
Lymphoid Malignancy	10 (45%)	7 (50%)	6 (43%)	0.89b
Myeloid Malignancy	11 (50%)	6 (43%)	6 (43%)
Other	1 (5%)	1 (7%)	2 (14%)
Conditioning Regimen:
Myeloablative:	14 (64%)	10 (71%)	8 (57%)	0.73b
Nonmyeloablative:	8 (36%)	4 (29%)	6 (43%)
CMV Serology
D+/R+	15 (68%)	10 (71%)	7 (50%)	0.73b
D+/R-	3 (13%)	1 (7%)	3 (21%)
D-/R+	4 (18%)	3 (21%)	4 (29%)

^aKruskal-Wallis test

^bFisher's exact test or Chi-square test

^cLog-rank test